Corradini Paolo

INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia / C. Papayannidis, E. Petracci, P. Zappasodi, N. Fracchiolla, F. Ciceri, C. Sartor, E. Roncoroni, F. Di Raimondo, D. Mattei, M.B. Giannini, F. Lanza, M. Gottardi, M.I. Del Principe, E. Borlenghi, M. Fumagalli, D. Vallisa, S. Sica, N. Di Renzo, F. Fabbiano, E. Todisco, P. de Fabritiis, M. Luppi, F. Passamonti, P. Corradini, F. Petruzziello, F. Pane, F. Ferrara, G. Mambelli, R. Volpi, F. Frabetti, C. Zingaretti, G. Marconi, G. Martinelli. - In: CANCER. - ISSN 0008-543X. - 131:7(2025 Apr 01), pp. e35820.1-e35820.10. [10.1002/cncr.35820]

Prognostic role of interim PET in patients with follicular lymphoma: a post-hoc study of FOLL12 trial by FIL / R. Durmo, S. Chauvie, F. Fallanca, F. Bergesio, A. Pinto, I. Del Giudice, M. Coscia, P. Corradini, E. Angelucci, P. Tosi, R. Freilone, F. Ballerini, A. Bari, D. Pastore, P.L.L. Zinzani, S.A.M. Bolis, L. Flenghi, A. Liso, J. Olivieri, L. Marcheselli, M. Merli, A. Versari, L. Guerra, S. Luminari. - In: BLOOD ADVANCES. - ISSN 2473-9537. - (2025), pp. 1-19. [Epub ahead of print] [10.1182/bloodadvances.2024014790]

Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD / C. Rusconi, A. Barone, A. Visentin, B. Bianchi, V.R. Zilioli, A. Bernardelli, S. Iadecola, E. Olivari, F.G. Rossi, M. Gotti, C. Cecchetti, B. Puccini, S. Franceschetti, A. Molteni, S. Steffanoni, F. Marino, A. Vanazzi, A. Guidetti, M. Merli, F. Mazzon, A. Marchetti, A. Cellini, C. Muzi, R. Miceli, C. Visco, A. Re, P. Corradini. - In: LEUKEMIA & LYMPHOMA. - ISSN 1029-2403. - 66:5(2025), pp. 879-887. [10.1080/10428194.2024.2446609]

Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study / F. Stella, A. Chiappella, M. Magni, F. Bonifazi, C. De Philippis, M. Musso, I. Cutini, S. Ljevar, A.M. Barbui, M. Farina, M. Martino, M. Massaia, G. Grillo, P. Angelillo, B. Botto, F. Patriarca, M. Krampera, L. Arcaini, M.C. Tisi, P. Zinzani, F. Sorà, S. Bramanti, M. Pennisi, C. Carniti, P. Corradini. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 1365-2141. - (2025), pp. 1-8. [Epub ahead of print] [10.1111/bjh.19961]

Prospective Validation of CAR-HEMATOTOX and a simplified version predict Survival in Patients with Large B-Cell Lymphoma treated with anti-CD19 CAR T-cells: data from CART-SIE study / F. Stella, M. Pennisi, A. Chiappella, B. Casadei, S. Bramanti, S. Ljevar, P. Chiusolo, A.D. Rocco, M.C. Tisi, P. Angelillo, I. Cutini, M. Martino, A. Barone, F. Bonifazi, A. Santoro, F. Sorà, M. Novo, A.M. Barbui, D. Russo, M. Musso, G. Grillo, M. Krampera, J. Olivieri, L. Brunello, F. Cavallo, M. Massaia, L. Arcaini, L. Farina, P. Zinzani, R. Miceli, P. Corradini. - In: TRANSPLANTATION AND CELLULAR THERAPY. - ISSN 2666-6367. - 31:4(2025), pp. 1-9. [10.1016/j.jtct.2025.01.888]